Initial Point of Entry to the Health Care System May Affect Downstream Quality of Breast Cancer Care

2021 ◽  
Author(s):  
Garth H. Rauscher ◽  
Yamilé Molina ◽  
Abigail Silva ◽  
Anne Marie Murphy
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Health Care System ◽  
Cancer Care ◽  
Initial Point ◽  
Breast Cancer Care ◽  
Point Of Entry ◽  
Care System

scholarly journals The Structural Landscape of the Health Care System for Breast Cancer Care: Results from The Los Angeles Women’s Health Study

2009 ◽  
Vol 15 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Diana M. Tisnado ◽  
Jennifer L. Malin ◽  
May L. Tao ◽  
Patricia Ganz ◽  
Danielle Rose-Ash ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Los Angeles ◽  
Women’S Health ◽  
Women's Health ◽  
Health Care System ◽  
Cancer Care ◽  
Health Study ◽  
Breast Cancer Care ◽  
Care System

scholarly journals Oncosmart: A Private Initiative to Improve Breast Cancer Care in Costa Rica

2018 ◽  
Vol 4 (Supplement 3) ◽  
pp. 48s-48s
Author(s):  
Andres Wiernik ◽  
Loretta Fernandez ◽  
Leonardo Lami ◽  
Greivin Vindas ◽  
Marissa Durman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Cancer Screening ◽  
Costa Rica ◽  
Health Care System ◽  
Cancer Care ◽  
Breast Cancer Care ◽  
Private Initiative ◽  
Advisory Role ◽  
Care System

Purpose Founded in 2010, Hospital Metropolitano is the fastest growing health care system in Costa Rica with a network of two hospitals, 27 clinics, and more than 90,000 patients enrolled in its health plan, Medismart. Given the challenges faced by the national public health care system in providing cancer care, the Oncosmart program was launched in November 2016 with the goal of providing population-based cancer screening, diagnostics, cancer treatment, and survivorship care. The program has no restrictions on preexisting conditions and has a monthly membership cost of $14 USD per patient. Here, we summarize our breast cancer program results during the first 16 months of implementation. Methods We performed a retrospective analysis that evaluated data from our radiology department, cancer center, and survivorship program. We determined the number of patients with breast cancer who were diagnosed and/or received care in our health care system from November 2016 to March 2018. Results During this period analyzed, 5,687 mammograms were performed at our health care system and 215 patients were reported to have a Breast Imaging Reporting and Data System 4 to 5 requiring a breast biopsy. Of these, 24% were diagnosed with breast cancer, 36% had a nonmalignant breast condition, and 41% were false positives. Among patients with newly diagnosed breast cancer, 11% had noninvasive breast cancer and 89% had invasive disease. Twenty-seven percent of all breast cancer diagnosis occurred in women younger than age 50 years and two patients were diagnosed with a BRCA1/2 mutation. All biopsies performed at our program were reported within 30 days from abnormal imaging. During this period, we performed 53 breast cancer surgeries and provided chemotherapy and/or endocrine therapy to 32 patients, and among all patients who followed-up in the survivorship clinic, 22 followed-up for breast cancer survivorship. Conclusion Oncosmart is a low-cost and effective private initiative that improves access to breast cancer screening and breast cancer care in the middle-income country of Costa Rica. On the basis of national statistics, after 16 months of implementation, approximately 4% to 5% of all patients with breast cancer in the country are diagnosed within our program. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc . Andres Wiernik Consulting or Advisory Role: Grupo Montecristo Leonardo Lami Employment: Roche, Genetech (I) Travel, Accommodations, Expenses: Roche/Genetech (I) Marissa Durman Consulting or Advisory Role: Grupo Montecristo

scholarly journals Facility Characteristics and Quality of Lung Cancer Care in an Integrated Health Care System

2014 ◽  
Vol 9 (4) ◽  
pp. 447-455 ◽  
Author(s):  
Joan J. Ryoo ◽  
Jennifer L. Malin ◽  
Diana L. Ordin ◽  
Sabine M. Oishi ◽  
Benjamin Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Health Care ◽  
Health Care System ◽  
Cancer Care ◽  
Integrated Health Care ◽  
Integrated Health ◽  
Integrated Health Care System ◽  
Care System

Assessing Costs and Value for Money

2019 ◽  
pp. 289-297
Author(s):  
Manuela Joore ◽  
Xavier Pouwels ◽  
Bram Ramaekers
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Health Care Providers ◽  
Cancer Care ◽  
Impact Analysis ◽  
Care Providers ◽  
Breast Cancer Care ◽  
Health Economic Analysis ◽  
Illness Study

Abstract: This chapter focuses on the economics of breast cancer care, describing the substantial and rising costs of breast cancer care due to increasing patient numbers and increasing costs of novel therapies. This is a major concern for stakeholders on different levels: health care providers and managers, health care insurers, and government. To assist these stakeholders in making decisions to secure the quality of breast cancer care while costs are rising and budgets are under pressure, several health economic analysis methods are available. These methods (cost-off-illness study, budget-impact analysis, and economic evaluation) provide information on the economic burden of breast cancer and the affordability and efficiency of breast cancer care, and are briefly described, while suggestions for further reading are provided.

Ensuring quality of dermatologic care in the US health care system

1997 ◽  
Vol 133 (11) ◽  
pp. 1355-1357 ◽  
Author(s):  
M. L. Johnson
Keyword(s):  
Health Care ◽  
Health Care System ◽  
The Us ◽  
Care System

Assisting People With Their Living, Not Their Dying: Health Professionals’ Perspectives of Palliative Care and Opioids in ILD

2021 ◽  
pp. 104990912110186
Author(s):  
Lauren Russo ◽  
Karen Willis ◽  
Natasha Smallwood
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Palliative Care ◽  
Health Care System ◽  
Therapeutic Relationships ◽  
Specialist Palliative Care ◽  
Cross Sectional ◽  
Symptom Palliation ◽  
Care System

Objectives: Interstitial lung disease (ILD) is a debilitating and life-limiting condition, requiring multi-disciplinary care. While guidelines recommend early specialist palliative care referral to improve symptoms and quality of life, few patients access such care towards the end-of-life. This study aimed to explore clinicians’ perspectives regarding specialist palliative care and opioids to understand barriers to optimal care and guide clinical practice improvement initiatives. Methods: A cross-sectional, exploratory, qualitative study was undertaken with Australian respiratory clinicians caring for people with ILD (n = 17). In-depth, semi-structured interviews were audio-recorded, transcribed verbatim and coded. Thematic analysis was undertaken to extrapolate recurring ideas from the data. Results: Four themes were identified: 1) understanding how to improve patient care and support, 2) the need to dispel stigmatized beliefs and misconceptions, 3) the importance of trusted relationships and good communication and 4) the challenges of navigating the health-care system. Participants discussed the need to implement early specialist palliative care and symptom palliation to alleviate symptoms, provide emotional support and augment quality of life. Participants described challenges accessing palliative care and opioids due to stigmatized beliefs amongst patients and clinicians and difficulties navigating the health-care system. Trusted therapeutic relationships with patients and strong inter-disciplinary partnerships with collaborative education and communication were perceived to improve patients’ access to symptom palliation. Conclusion: Specialist palliative care and opioids were believed to improve patients’ quality of life, however, many barriers can make accessing such care challenging. To address these issues, multi-disciplinary collaboration, high-quality communication and trusted therapeutic relationships are crucial throughout the ILD illness journey.

The patient’s perspective of the quality of breast cancer care

2007 ◽  
Vol 43 (8) ◽  
pp. 1257-1264 ◽  
Author(s):  
Mascha de Kok ◽  
Rachel W. Scholte ◽  
Herman J. Sixma ◽  
Trudy van der Weijden ◽  
Karin F. Spijkers ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Care ◽  
Breast Cancer Care ◽  
Patient’S Perspective

Evaluation of Breast Cancer Care under Puerto Rico's Health Care Reform

2007 ◽  
Vol 18 (1) ◽  
pp. 116-138 ◽  
Author(s):  
Thomas N. Chirikos ◽  
Josefina. López-Garcia ◽  
Cristóbal. Cintrón Vargas ◽  
Omayra L. Gonzalez ◽  
Maria P. Pérez-Grau ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Health Care Reform ◽  
Cancer Care ◽  
Breast Cancer Care

The role of transformative healthcare technology on quality of life during the COVID-19 pandemic

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Mohammad Asif Salam ◽  
Saleh Bajaba
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Saudi Arabia ◽  
Service Delivery ◽  
Health Care System ◽  
Service System ◽  
Content Type ◽  
Care System

Purpose The purpose of this study is to investigate the role of the COVID-19 health-care system quality (HSQ) and its impact on the individual (satisfaction) and social (quality of life [QOL]) outcomes in the context of a transformative health-care delivery system using service-dominant logic (SDL). Design/methodology/approach A sample consisting of 1,008 individuals who have experienced the COVID-19 health-care system was drawn from four different regions of Saudi Arabia using the simple random sampling technique. The survey was conducted using an online survey and 1,008 respondents answered, based on their experience and knowledge of the COVID-19 health-care system. Partial least squares structural equation modeling was applied to test the proposed research model. Findings The study findings suggest that service system satisfaction (SAT) significantly mediates the role of the HSQ in delivering and enhancing the QOL. HSQ also has a significant role to play on the SAT as well as the QOL. These findings contribute to the body of knowledge on SDL in the context of HSQ in understanding the significant role of technologies can play in enhancing service satisfaction and better QOL during a crisis such as COVID-19. This study also improves the understanding of the importance of customer-centricity, real-time visibility through tracking and tracing of service flow, agile decision-making, fewer but better-defined service objectives, and finally shaping mindsets and behaviors of all the relevant parties involved in the HSQ service delivery process. Research limitations/implications One of the major limitations of this study is that, although COVID-19 is an ongoing global pandemic, cross-sectional data were collected in only one country. The findings may not be generalizable across subsequent waves of the pandemic. The best practices of HSQ could be studied around the globe and the results used to support continuous improvement. Originality/value This study advances the understanding of the SDL in the context of a transformative health-care system for a transitional economy by focusing on individual and social well-being during an unexpected crisis such as the COVID-19 pandemic. This study also contributes toward the understanding of the roles of enabling technologies to improve the service delivery system which results in an improved SAT, as well as better QOL for the society at large. Based on SDL this research validates the HSQ model, relevant measures and its overall impact on SAT and QOL in the context of a transformative health-care service system in Saudi Arabia.

Sign in / Sign up

Export Citation Format

Share Document